Global Pneumococcal Vaccine Market 2016-2020
- Published: Aug 2016
- Pages: 82
- SKU: IRTNTR10147
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
This market study report presents a detailed analysis of the key players in the global pneumococcal vaccine market, including vendors like Pfizer, Sanofi, GSK, and Merck. It also provides a comprehensive analysis of the key drivers, trends, and challenges that influence market growth and further segments the market based on geography (the Americas, APAC, and EMEA).
Pneumococcal vaccine market outlook
In terms of volume, the global market for pneumococcal vaccines will grow at a CAGR of over 8% by 2020. The high demand for vaccines with a broad serotype coverage is a critical factor impelling this market’s growth prospects over the next few years. Recently, there has been an increase in pneumococcal diseases because of causative serotype. This serotype shift has created the need for vaccines with broader coverage as the available vaccines are not effective against all serotypes. The seven serotype (4, 6B, 14, 19F, 18C, 23F, 9V) contained in PCV 7 were among the most common causes of invasive pneumococcal disease (IPD) in children aged less than five years. As a result, the demand for newer pneumococcal vaccines with a broader serotype coverage has increased significantly.
Another eminent factor fostering this market’s growth prospects is the advent of protein-based combination pneumococcal vaccines. At present, numerous new pneumococcal protein-based vaccines are undergoing clinical trial evaluations. These vaccines consist of serotype-independent subunit vaccines, which contain purified proteins and antigens that are expressed by the recombinant bacteria. These vaccines help avoid the problems of serotype replacement by directly targeting proteins that are highly preserved among many pneumococcal serotypes.
Pneumococcal vaccine market forecasts: Competitive landscape and key vendors
The global pneumococcal vaccine market is competitive and is primarily dominated by the vendor Pfizer. In this market, Pfizer dominates over the other vendors in terms of shares owing to its robust vaccine product, Prevnar, which generated revenues of over USD 6 billion in 2015.
Key vendors in the pneumococcal vaccine market
- Pfizer
- Sanofi
- GSK
- Merck
Pneumococcal vaccine market regions
- Americas
- APAC
- EMEA
During 2015, the Americas dominated this market by accounting for a market share of more than 45%. The market in this region is flourishing owing to the high incidence of pneumococcal infections in the US, which, in turn, results in the increased consumption of pneumococcal vaccines. Moreover, with the increasing use of combination vaccines and the introduction of novel vaccines, this market will have a positive outlook until the end of the forecast period.
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the global pneumococcal vaccine market?
- What are the key market trends impacting the growth of the global pneumococcal vaccine market?
- What are the challenges to market growth?
- Who are the key vendors in the global pneumococcal vaccine market?
- What are the market opportunities and threats faced by the vendors in the global pneumococcal vaccine market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of global pneumococcal vaccine market?
Technavio also offers customization on reports based on specific client requirement.
Related reports
Table of Contents
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Pneumococcal vaccine: Overview
- Vaccine approval process
PART 06: Market landscape
- Market overview
- Five forces analysis
- Market segmentation by composition
- Global PCV market
- Market overview
- Global PPV market
- Market overview
PART 07: Geographical segmentation
- Pneumococcal vaccine market in Americas
- Pneumococcal vaccine market in EMEA
- Pneumococcal vaccines market in APAC
PART 08: Market drivers
- Inclusion in NIP
- Broad serotype coverage
- Global action plans for pneumonia vaccines
PART 09: Impact of drivers
PART 10: Market challenges
- Inadequate vaccine coverage
- Require cold storage
- High risk and cost involved in vaccine development
- Stringent regulatory guidelines
PART 11: Impact of drivers and challenges
PART 12: Market trends
- Expansion of marketing territories
- Emergence of protein-based combination pneumococcal vaccines
- AMC for pneumococcal vaccines
- Bio-terrorism
- Public–private initiatives
PART 13: Vendor landscape
- Competitive scenario
- Key news
- Pfizer
- Sanofi
- GSK
- Merck
- Other prominent vendors
PART 14: Appendix
- List of abbreviations
PART 15: Explore Technavio
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
